Chemical Formula: C10H14N2O
Chemical Formula C10H14N2O
Found 122 metabolite its formula value is C10H14N2O
Pseudooxynicotine
Nicorette is a branded over-the-counter palliative treatment which is used to ameliorate the withdrawal effects involved in quitting smoking. Originally available as a patch for topical application, it was later made available as a nicotine gum (composed of nicotine polacrilex)lozenge, inhaler, and nasal spray. All these products contain nicotine as the active ingredient and work by delivering this into the bloodstream. [HMDB] Nicorette is a branded over-the-counter palliative treatment which is used to ameliorate the withdrawal effects involved in quitting smoking. Originally available as a patch for topical application, it was later made available as a nicotine gum (composed of nicotine polacrilex)lozenge, inhaler, and nasal spray. All these products contain nicotine as the active ingredient and work by delivering this into the bloodstream.
Glycinexylidide
Glycinexylidide is a metabolite of lidocaine. Lidocaine, Xylocaine, or lignocaine is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery. (Wikipedia)
Nicotine-1'-N-oxide
Nicotine N-oxide (NNO) is a primary metabolite of nicotine, although only about 4-7\\% of nicotine absorbed by smokers is metabolized via this route. The conversion of nicotine to NNO involves a flavin-containing monooxygenase 3 (FMO3). It appears that NNO is not further metabolized to any significant extent, except by reduction back to nicotine, which may lead to recycling of nicotine in the body. [HMDB]. Nicotine-1-N-oxide is found in many foods, some of which are thistle, swede, sorghum, and pulses. Nicotine N-oxide (NNO) is a primary metabolite of nicotine, although only about 4-7\\% of nicotine absorbed by smokers is metabolized via this route. The conversion of nicotine to NNO involves a flavin-containing monooxygenase 3 (FMO3). It appears that NNO is not further metabolized to any significant extent, except by reduction back to nicotine, which may lead to recycling of nicotine in the body.
2'-Hydroxynicotine
2-Hydroxynicotine is a metabolite produced from the degradation of nicotine, an alkaloid found in the nightshade family of plants (Solanaceae), predominantly in tobacco, and in lower quantities in tomato, potato, eggplant (aubergine), and green pepper. Cytochrome P450 2A6 (EC 1.14.14.1) metabolizes nicotine via 2-hydroxylation into 4-(methylamino)-1-(3-pyridyl)-1-butanone with 2-hydroxynicotine as an intermediate (PMID: 11050152). 2-Hydroxynicotine spontaneously yields nicotine-Δ1′(2′)-iminium ion, which is in equilibrium with 4-(methylamino)-1-(3-pyridyl)-1-butanone (PMID: 15734728). About 10\\% of nicotine and its metabolites are excreted as 4-oxo-4-(3-pyridyl)butanoate (keto acid) and 4-hydroxy-4-(3-pyridyl)butanoate (hydroxy acid) in the urine of smokers (PMID: 10548320). 2-Hydroxynicotine is a metabolite of the degradation of Nicotine (Nicotine is an alkaloid found in the nightshade family of plants (Solanaceae), predominantly in tobacco, and in lower quantities in tomato, potato, eggplant (aubergine), and green pepper) via a 2-hydroxylation reaction producing 2-hydroxynicotine as an intermediate in the cytochrome P450 2A6 [EC 1.14.14.1] catalyzed conversion of nicotine to 4-(methylamino)-1-(3-pyridyl)-1-butanone. 2-Hydroxynicotine spontaneously yields nicotine-1(2)-iminium ion, which is in equilibrium with 4-(methylamino)-1-(3-pyridyl)-1-butanone. About 10\\% of nicotine and metabolites is excreted as 4-oxo-4-(3-pyridyl)butanoate (keto acid) and 4-hydroxy-4-(3-pyridyl)butanoate (hydroxy acid) in the urine of smokers. [HMDB]
Nikethamide
R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Nikethamide
R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
isoproturon-didemethyl
A member of the class of phenylureas that is urea substituted by a p-cumenyl group at position 1. It is a metabolite of the herbicide isoproturon. CONFIDENCE standard compound; EAWAG_UCHEM_ID 285
Nicotine 1-N-oxide
Trans-(S)-nicotine N(1)-oxide is an (S)-nicotine N(1)-oxide in which the N(1)-methyl group is on the opposite side of the pyrrolidine ring to the pyridine substituent. The major species at pH 7.3. (1′S,2′S)-Nicotine-1'-oxide is an alkaloid N-oxide from the leaves, stems and roots of Nicotiana tabacum[1].
2-Amino-n-isopropylbenzamide
CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6321; ORIGINAL_PRECURSOR_SCAN_NO 6319 CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6352; ORIGINAL_PRECURSOR_SCAN_NO 6351 CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6349; ORIGINAL_PRECURSOR_SCAN_NO 6346 CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6378; ORIGINAL_PRECURSOR_SCAN_NO 6375 CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6378; ORIGINAL_PRECURSOR_SCAN_NO 6374 CONFIDENCE standard compound; INTERNAL_ID 680; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6396; ORIGINAL_PRECURSOR_SCAN_NO 6394
pseudooxynicotine
An aminoacylpyridine that is pyridine substituted at position 3 by a 4-(methylamino)butanoyl group.
7-(DIFLUOROMETHYL)-5-METHYL-4,5,6,7-TETRAHYDRO-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID
6-CYCLOPROPYL-3-METHYL-ISOXAZOLO[5,4-B]PYRIDINE-4-CARBOXYLIC ACID
(4-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)Methanamine
3-(3-aminophenyl)-N-methylpropanamide(SALTDATA: 2HCl)
(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanamine
3,6,6-TRIMETHYL-1,5,6,7-TETRAHYDRO-4H-INDAZOL-4-ONE
2-(METHYLAMINO)-N-(4-METHYLPHENYL)ACETAMIDE HYDROCHLORIDE
8-HYDROXYMETHYL-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPIN
Pyridine, 3-((1R,2S)-1-methyl-1-oxido-2-pyrrolidinyl)-
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro-3,6-dimethyl-
Glycinexylidide
A amino acid amide with 2,6-dimethylaniline and glycine components; an active metabolite of lidocaine, formed by oxidative deethylation. Used as an indicator of hepatic function.